Before prescribing ONTRUZANT, please read the accompanying
Prescribing Information, including the Boxed Warning about cardiomyopathy,
infusion reactions (pulmonary toxicity), and embryo-fetal toxicity.
The Merck Access Program representatives can refer patients to the Merck Patient Assistance Program.
Patients who do not have insurance, or who cannot afford their prescribed Merck medicine even with prescription drug coverage, may be eligible for free product from the Merck Patient Assistance Program if they meet certain financial, medical, and/or insurance criteria.